CION Ameerpet
A breast cancer diagnosis while you are pregnant is frightening — but it does not mean choosing between your treatment and your baby. With the right timing, most women can have surgery and certain chemotherapy safely during pregnancy and carry to a healthy delivery. At CION Cancer Clinics in Hyderabad, our tumor board works alongside your obstetrician to plan care for both of you, together.
Breast cancer found during pregnancy or in the first year after delivery is called pregnancy-associated breast cancer (PABC). It is uncommon — roughly 1 in 3,000 pregnancies — but it is the second most common cancer diagnosed in pregnant women, most often between ages 32 and 38. In India, the picture is sobering: a registry of pregnancy-associated breast cancer from Tata Memorial Centre reported a median age of just 31 years, and 74% of women had a delay of three months or more before diagnosis was confirmed.[1]
The reason it is missed is simple and human. Pregnancy already makes breasts larger, denser, lumpy and tender, so a new lump can be dismissed as a normal pregnancy change — by the patient, and sometimes by the first doctor she sees. Any lump that persists for more than two weeks, a bloody or one-sided nipple discharge, skin thickening, dimpling or an inverted nipple deserves a proper check, no matter how many weeks pregnant you are.
A firm, painless lump in the breast or armpit that stays for more than 2 weeks should never be assumed to be a pregnancy change — it needs an ultrasound.
Bloody or clear one-sided nipple discharge, a newly inverted nipple, skin dimpling, redness or an orange-peel texture are all warning signs worth checking.
Dense, lumpy, tender pregnancy breasts hide tumours and make self-exam harder, so cancers are often found at a later stage than in non-pregnant women.
Delaying a check until after the baby arrives is the most common avoidable mistake. A safe ultrasound and, if needed, a biopsy can be done while you are pregnant.
In an Indian registry of pregnancy-associated breast cancer from Tata Memorial Centre, the median age at diagnosis was just 31 years, and about 74% of women had a delay of three months or more before the diagnosis was confirmed — usually because a lump was mistaken for a normal pregnancy change. Source: Tata Memorial Centre PABC registry.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Yes — for most women, breast cancer can be treated during pregnancy without harming the baby, provided the timing of each treatment is matched to the trimester. The goal is never to choose between your health and your child's; it is to sequence treatment so both are protected. This is exactly the kind of decision that should be made by a tumor board — oncologists and your obstetrician together — and not by a single doctor under pressure. Below is the general framework your CION team will personalise to your stage, tumour type and how far along you are.
Surgery is generally safe. Chemotherapy is avoided here because the baby's organs are forming and the risk of birth defects and miscarriage is highest. If chemo is clinically essential, it is usually deferred to the second trimester.
Considered the safest window. Surgery (lumpectomy or mastectomy) and certain chemotherapy regimens can both be given, as the placenta now offers more protection and most organ development is complete.
Surgery and chemotherapy can continue, but chemo is stopped after about week 35 — or within 3 weeks of the planned delivery — so that the mother's and baby's blood counts recover before birth.
Your obstetrician, medical oncologist, surgical oncologist and a neonatologist agree the plan together. No step is taken without weighing the effect on both mother and baby.
A diagnosis like this needs more than a single breast cancer specialist — it needs a team that can hold oncology and obstetrics in the same room. CION is a woman-headed, tumor-board-led organisation built for exactly these complex, high-stakes decisions, with transparent costs and no rushed calls.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Tumor-board-led breast cancer care coordinated with your obstetrician, across 35+ centres in Telangana & AP. Call 1800-202-8726.
Diagnosis comes first, and it can be done safely. Breast ultrasound is the preferred first test in pregnancy — no radiation, safe for the baby. A mammogram can be added with an abdominal shield if needed, and a core-needle biopsy is safe at any stage to confirm the diagnosis. For staging, your team will favour ultrasound and non-contrast MRI and avoid CT and PET-CT, which involve fetal radiation. Once the diagnosis is clear, treatments fall into two groups — those that can be given during pregnancy, and those that are safely held until after delivery.
Both breast-conserving surgery (lumpectomy) and mastectomy can be performed during pregnancy, most safely in the second trimester. Anaesthesia crosses the placenta but, when given by an experienced team coordinating with your obstetrician, has not been shown to cause birth defects. Lymph node assessment is part of surgery; sentinel node biopsy using a radioactive tracer can usually be done, while blue dye is avoided in pregnancy.
Certain regimens (commonly doxorubicin and cyclophosphamide, with a taxane such as paclitaxel in some cases) are considered relatively safe in the second and third trimesters. Chemo is never given in the first trimester, and is stopped after roughly week 35 or within 3 weeks of delivery so blood counts recover. It is restarted around a week after an uncomplicated delivery.
Radiation is generally not given during pregnancy because of the dose reaching the baby. If you have breast-conserving surgery, radiation is typically scheduled for after you deliver. Your team plans the surgery so this delay does not compromise your outcome.
Tamoxifen and aromatase inhibitors (anastrozole, letrozole, exemestane) are not used during pregnancy because they can harm the developing baby. For hormone-receptor-positive cancers, this treatment begins after delivery and, where relevant, after breastfeeding decisions are made.
Trastuzumab, pertuzumab and similar HER2 drugs are avoided in pregnancy because they can reduce amniotic fluid and affect the baby's kidneys and lungs. For HER2-positive cancers, these are started once the baby is delivered.
Immunotherapy, CDK4/6 inhibitors and mTOR inhibitors are not used during pregnancy due to limited safety data and potential fetal harm. They are reserved for after delivery when indicated by your tumour type.
Every treatment choice is filtered through one question: how does this affect the baby? When care is timed correctly, the evidence is reassuring — large studies show children exposed to chemotherapy after the first trimester reach their developmental milestones normally. In the Indian Tata Memorial registry, the great majority of babies born to treated mothers were developing normally on follow-up.[1] Here is how your team keeps the baby safe at each step.
Ultrasound is used before anything involving radiation; CT and PET-CT are avoided. Where X-ray or mammography is essential, abdominal shielding is used.
Chemotherapy is kept out of the first trimester entirely and stopped before delivery, so the baby is never exposed during organ formation or at birth.
Your obstetrician tracks the baby's growth, amniotic fluid and wellbeing across treatment, with scans timed around chemotherapy cycles.
Delivery is planned at a centre with newborn care available, so the baby has support on hand if delivery is brought slightly forward.
One of the most important — and most personal — decisions is when to deliver and how to sequence the rest of your treatment around it. The aim is a full-term, healthy delivery wherever possible, with cancer treatment paused at the right moment and resumed promptly afterwards. There is rarely one 'correct' order; it depends on your stage, tumour type, and how many weeks pregnant you are when diagnosed.
Where the cancer allows, the goal is to reach at least 37 weeks. Very early induction is avoided unless the cancer needs treatment that can't wait.
Chemotherapy is stopped about 3 weeks before delivery so the mother's and baby's blood counts recover, lowering the risk of bleeding and infection at birth.
Chemo can usually restart around a week after an uncomplicated delivery. Radiation, hormone and HER2 therapy that were on hold begin once you have recovered.
Surgery may come first, or after some chemotherapy (neoadjuvant), depending on tumour size and stage — your tumor board decides the order that protects both of you best.
After your baby arrives, two questions come up most: can I breastfeed, and what happens next? The honest answer on breastfeeding depends on which treatment you are receiving. The good news on follow-up is that, stage for stage, survival for breast cancer diagnosed in pregnancy is broadly similar to that of non-pregnant women — which is exactly why catching it and treating it on time matters so much.
While you are on chemotherapy, hormone therapy or HER2-targeted drugs, breastfeeding is not advised because the drugs pass into breast milk. Your team will guide safe timing if you wish to feed between phases.
Women who had a single mastectomy can often breastfeed from the remaining breast. After lumpectomy and radiation, the treated breast may produce little or no milk, but the other breast can usually feed.
After active treatment you move into structured follow-up — clinical exams and imaging on a schedule — to catch any recurrence early, since the post-partum period needs close attention.
A prior pregnancy does not appear to raise recurrence risk, but some treatments affect fertility. Ask about fertility preservation before treatment starts, and about safe timing for any future pregnancy.
What sets pregnancy care apart is coordination. CION's tumor board reviews your case with your obstetrician and, where needed, a neonatologist, so every decision — imaging, surgery timing, chemo cycles, delivery date — is made by the same team, not handed between disconnected clinics. Catching breast cancer early changes outcomes dramatically: CION's 1-year breast cancer survival is 96.9% against a national average of 85.4% (+11.5%).* The single biggest factor you can control is not waiting — book a check the moment something feels wrong.
CION breast cancer 1-year survival: 96.9% vs national average 85.4% (+11.5%). *1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP).
Stories from women who were treated for breast cancer during or soon after pregnancy at CION — shared with consent.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Breast cancer itself is extremely unlikely to spread to or harm your baby — cases of the cancer reaching the fetus are exceptionally rare. The risks to a baby come from certain treatments given at the wrong time, not from the cancer. This is why timing matters so much: surgery is safe in any trimester, and certain chemotherapy is safe from the second trimester onward, while radiation, hormone and HER2 therapy are held until after delivery. With a coordinated oncology-obstetrics plan, most women carry to a healthy, full-term delivery. The most important step you can take is not to delay diagnosis — a safe ultrasound can be done while you are pregnant.
Chemotherapy is not given in the first trimester, when the baby's organs are forming and the risk of birth defects and miscarriage is highest. From the second trimester onward, certain regimens — commonly doxorubicin and cyclophosphamide, sometimes a taxane like paclitaxel — are considered relatively safe, and studies show children exposed after the first trimester reach their milestones normally. Chemotherapy is stopped after around week 35, or within 3 weeks of delivery, so the mother's and baby's blood counts recover before birth, then usually restarts about a week after an uncomplicated delivery. Your CION tumor board decides the exact regimen and timing with your obstetrician.
Radiation therapy, hormone (endocrine) therapy such as tamoxifen and aromatase inhibitors, HER2-targeted drugs such as trastuzumab and pertuzumab, and immunotherapy are all avoided during pregnancy because they can harm the developing baby. For example, HER2 drugs can reduce amniotic fluid and affect the baby's kidneys and lungs, and hormone drugs interfere with development. These treatments are not cancelled — they are sequenced to begin after delivery once you have recovered. Surgery and certain chemotherapy can be given during pregnancy in the meantime, so treatment does not have to stop entirely while you wait.
Pregnancy naturally makes the breasts larger, denser, lumpier and more tender, so a new cancerous lump is easily mistaken for a normal pregnancy change — by women and sometimes by the first doctor they see. In an Indian registry from Tata Memorial Centre, about 74% of women with pregnancy-associated breast cancer had a delay of three months or more before diagnosis. That delay often means the cancer is found at a more advanced stage. The lesson is simple: any lump that lasts more than two weeks, or any nipple discharge, skin dimpling or inverted nipple, should be checked with an ultrasound — being pregnant is not a reason to wait.
In most cases, yes. The aim is a full-term delivery wherever the cancer allows, ideally at or beyond 37 weeks. Chemotherapy is stopped about three weeks before the planned delivery so blood counts recover and the risk of bleeding and infection is reduced. Whether you have a vaginal delivery or caesarean is decided with your obstetrician based on usual obstetric factors, not the cancer alone. Delivery is planned at a centre with newborn care available in case treatment requires bringing the date slightly forward. After an uncomplicated delivery, chemotherapy and any treatments that were on hold can resume.
It depends on your treatment. While you are on chemotherapy, hormone therapy or HER2-targeted drugs, breastfeeding is not advised because the drugs pass into breast milk. After surgery, women who had a single mastectomy can often breastfeed from the remaining breast; after a lumpectomy with radiation, the treated breast may make little milk, but the other breast can usually feed. Your CION team will help you plan safe timing — including any chemo-free window — if breastfeeding is important to you. The decision is made for your and your baby's safety, and there is no single answer that applies to everyone.
Stage for stage, survival for breast cancer diagnosed in pregnancy is broadly similar to that of non-pregnant women of the same age and stage. The reason pregnancy-associated breast cancer sometimes has poorer outcomes is mainly that it is caught later and is more often a more aggressive subtype — not because pregnancy itself makes treatment less effective. That is why timely diagnosis and a coordinated, tumor-board-led treatment plan matter so much. At CION, 1-year breast cancer survival is 96.9% compared with a national average of 85.4%,* a gap driven by early, multidisciplinary care.
Get it checked without waiting for the baby to arrive. The first test is a breast ultrasound, which is completely safe during pregnancy and involves no radiation. If the ultrasound is suspicious, a core-needle biopsy — also safe in pregnancy — confirms the diagnosis. At CION Cancer Clinics in Hyderabad, your first 45-minute consultation is free; bring any reports or your obstetrician's notes. From there, our tumor board plans imaging, surgery timing and any chemotherapy around your trimester and delivery, coordinating directly with your obstetrician. Call 1800-202-8726 to book a free, confidential consultation.